FFA
CVS icon

Fairfield Financial Advisors’s CVS Health CVS Stock Holding History

Fairfield Financial Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-205
Closed -$9.2K – 101
2024
Q4 		$9.2K Sell
205
-488
-70% -$27.4K ﹤0.01% 207
2024
Q3 		$43.6K Buy
693
+8
+1% +$467 0.01% 149
2024
Q2 		$40.5K Buy
+685
New +$42.8K 0.01% 140
2023
Q4 		$79.2K Buy
1,003
+8
+0.8% +$569 0.03% 113
2023
Q3 		$69.5K Sell
995
-348
-26% -$24.7K 0.03% 112
2023
Q2 		$92.9K Buy
1,343
+11
+0.8% +$783 0.04% 100
2023
Q1 		$99.5K Buy
1,332
+9
+0.7% +$755 0.04% 100
2022
Q4 		$123K Buy
1,323
+7
+0.5% +$675 0.06% 86
2022
Q3 		$125K Buy
1,316
+8
+0.6% +$792 0.06% 81
2022
Q2 		$121K Buy
1,308
+7
+0.5% +$683 0.06% 79
2022
Q1 		$132K Buy
+1,301
New +$137K 0.05% 75

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fairfield Financial Advisors's CVS Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of CVS Health (CVS) in Q1 2025, closing a stake of 205 shares — an estimated $9.2K sold.

Fairfield Financial Advisors first reported a position in CVS in Q1 2022 and held it in 11 quarters. The position peaked at $132K in Q1 2022. 1,757 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Fairfield Financial Advisors reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Fairfield Financial Advisors sold 205 CVS Health shares in Q1 2025, an estimated $9.2K.
  • Fairfield Financial Advisors first reported a position in CVS Health in Q1 2022 and held it in 11 quarters.
  • Fairfield Financial Advisors's CVS Health position peaked at $132K in Q1 2022.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.